Logo
    • English
    • Ελληνικά
    • Deutsch
    • français
    • italiano
    • español
  • Ελληνικά 
    • English
    • Ελληνικά
    • Deutsch
    • français
    • italiano
    • español
  • Σύνδεση
Προβολή τεκμηρίου 
  •   Ιδρυματικό Αποθετήριο Πανεπιστημίου Θεσσαλίας
  • Επιστημονικές Δημοσιεύσεις Μελών ΠΘ (ΕΔΠΘ)
  • Δημοσιεύσεις σε περιοδικά, συνέδρια, κεφάλαια βιβλίων κλπ.
  • Προβολή τεκμηρίου
  •   Ιδρυματικό Αποθετήριο Πανεπιστημίου Θεσσαλίας
  • Επιστημονικές Δημοσιεύσεις Μελών ΠΘ (ΕΔΠΘ)
  • Δημοσιεύσεις σε περιοδικά, συνέδρια, κεφάλαια βιβλίων κλπ.
  • Προβολή τεκμηρίου
JavaScript is disabled for your browser. Some features of this site may not work without it.
Ιδρυματικό Αποθετήριο Πανεπιστημίου Θεσσαλίας
Όλο το DSpace
  • Κοινότητες & Συλλογές
  • Ανά ημερομηνία δημοσίευσης
  • Συγγραφείς
  • Τίτλοι
  • Λέξεις κλειδιά

Do Calcium Supplements Predispose to Urolithiasis?

Thumbnail
Συγγραφέας
Kozyrakis D., Paridis D., Karatzas A., Soukias G., Dailiana Z.
Ημερομηνία
2017
Γλώσσα
en
DOI
10.1007/s11934-017-0668-9
Λέξη-κλειδί
calcium
calcium carbonate
citrate calcium
parathyroid hormone[1-34]
placebo
vitamin D
calcium
vitamin
vitamin D
bone density
calcium urine level
diet supplementation
disease association
disease predisposition
drug safety
human
long term care
osteoporosis
pharmacodynamics
postmenopause
protection
randomized controlled trial (topic)
Review
risk assessment
stone formation
systematic review (topic)
urolithiasis
vitamin D deficiency
women's health
chemically induced
complication
dietary supplement
osteoporosis
urolithiasis
Calcium
Dietary Supplements
Humans
Osteoporosis
Urolithiasis
Vitamin D
Vitamins
Current Medicine Group LLC 1
Εμφάνιση Μεταδεδομένων
Επιτομή
Purpose of Review: The purpose of this study was to investigate the role of calcium supplements, with or without vitamin D, in urinary stone formation in healthy population and in osteoporotic patients as well. Moreover, this review aims to clarify whether or not, and above which dose, they are associated with the risk of lithiasis. Recent Findings: A research in Medline, Embase, and Scopus databases up to September 2015 was conducted using the following keywords: calcium, supplements, vitamin D, complications, lithiasis, and urinary stone. All types of studies were taken into account (cohort studies, reviews, meta-analyses), and in case they fulfilled the inclusion criteria, they were included in our review. The analysis of the data showed that calcium supplements, probably in association with anti osteoporotic treatment, do not create a predisposition towards lithiasis formation among women suffering from osteoporosis, neither among non-osteoporotic older men. In healthy postmenopausal as well as younger women, the supplements might increase susceptibility to urinary stone formation in long-term basis. The consumption of calcium supplements with the meals could play a protective role in women and younger males. There is certain evidence that supplements containing citrate may be more beneficial over the rest of calcium supplements, particularly when consumed during the meal. Summary: Osteoporotic women and healthy men are not at risk of stone formation. On the contrary, healthy women should be aware of the potential risk of developing urinary lithiasis in long-term basis. © 2017, Springer Science+Business Media New York.
URI
http://hdl.handle.net/11615/75492
Collections
  • Δημοσιεύσεις σε περιοδικά, συνέδρια, κεφάλαια βιβλίων κλπ. [19735]

Related items

Showing items related by title, author, creator and subject.

  • Thumbnail

    Vitamin K for the treatment of cardiovascular disease in end-stage renal disease patients: Is there hope? 

    Roumeliotis S., Roumeliotis A., Dounousi E., Eleftheriadis T., Liakopoulos V. (2020)
    In Chronic Kidney Disease, vascular calcification (VC) is highly prevalent even at early stages and is gradually enhanced, along with disease progression to End-Stage Renal Disease (ESRD). The calcification pattern in ...
  • Thumbnail

    VItamin K In PEritonial DIAlysis (VIKIPEDIA): Rationale and study protocol for a randomized controlled trial 

    Roumeliotis S., Roumeliotis A., Georgianos P.I., Thodis E., Schurgers L.J., Maresz K., Eleftheriadis T., Dounousi E., Tripepi G., Mallamaci F., Liakopoulos V. (2022)
    Vascular calcification (VC) is an active process, resulting from the disturbance of balance between inhibitors and promoters of calcification, in favor of the latter. Matrix Gla Protein, a powerful inhibitor of VC, needs ...
  • Thumbnail

    Fibroblast Growth Factor 23 (FGF23) and Klotho Protein in Beta-Thalassemia 

    Stefanopoulos D., Nasiri-Ansari N., Dontas I., Vryonidou A., Galanos A., Psaridi L., Fatouros I.G., Mastorakos G., Papavassiliou A.G., Kassi E., Tournis S. (2020)
    Derangements in phosphate and calcium homeostasis are common in patients with beta-thalassemia. Fibroblast growth factor 23 (FGF23) is among the main hormones regulating phosphate levels, while several studies underline ...
htmlmap 

 

Πλοήγηση

Όλο το DSpaceΚοινότητες & ΣυλλογέςΑνά ημερομηνία δημοσίευσηςΣυγγραφείςΤίτλοιΛέξεις κλειδιάΑυτή η συλλογήΑνά ημερομηνία δημοσίευσηςΣυγγραφείςΤίτλοιΛέξεις κλειδιά

Ο λογαριασμός μου

ΣύνδεσηΕγγραφή (MyDSpace)
Πληροφορίες-Επικοινωνία
ΑπόθεσηΣχετικά μεΒοήθειαΕπικοινωνήστε μαζί μας
Επιλογή ΓλώσσαςΌλο το DSpace
EnglishΕλληνικά
htmlmap